Insider · CIK 0001530920
Chelsea Clinton
director
Files at EXPE (Expedia Group, Inc.), PPLI (IAC Inc.), CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | EXPE Expedia Group, Inc. | AGrant or award Stock Unitsderivative | +49 | $0.00 | $0 | 2,970 | 7 d ago |
| Sep 30, 2026 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +148 | $41.96 | $6,210 | 93,484 | 10 d ago |
| Jan 1, 2026 | EXPE Expedia Group, Inc. | AGrant or award Stock Unitsderivative | +45 | $0.00 | $0 | 2,831 | Jan 5, 2026 |
| Dec 31, 2025 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +160 | $39.10 | $6,256 | 87,097 | Jan 5, 2026 |
| Oct 1, 2025 | EXPE Expedia Group, Inc. | AGrant or award Stock Unitsderivative | +59 | $0.00 | $0 | 2,786 | Oct 2, 2025 |
| Sep 30, 2025 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +183 | $34.07 | $6,235 | 86,937 | Oct 2, 2025 |
| Jul 1, 2025 | EXPE Expedia Group, Inc. | AGrant or award Stock Unitsderivative | +57 | $0.00 | $0 | 2,727 | Jul 2, 2025 |
| Jun 30, 2025 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +167 | $37.34 | $6,236 | 80,633 | Jul 2, 2025 |
| Jun 23, 2025 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +1,257 | $0.00 | $0 | 80,466 | Jun 25, 2025 |
| Jun 23, 2025 | PPLI IAC Inc. | MOption exercise Restricted Stock Unitsderivative | -1,257 | $0.00 | $0 | 0 | Jun 25, 2025 |
| Jun 18, 2025 | PPLI IAC Inc. | AGrant or award Restricted Stock Unitsderivative | +6,791 | $0.00 | $0 | 6,791 | Jun 23, 2025 |
| Jun 15, 2025 | PPLI IAC Inc. | MOption exercise Common Stock, par value $0.0001 | +1,610 | $0.00 | $0 | 79,209 | Jun 17, 2025 |
| Jun 15, 2025 | PPLI IAC Inc. | MOption exercise Restricted Stock Unitsderivative | -1,610 | $0.00 | $0 | 1,609 | Jun 17, 2025 |
| Jun 11, 2025 | PPLI IAC Inc. | MOption exercise Common Stock, par value $0.0001 | +2,076 | $0.00 | $0 | 77,599 | Jun 13, 2025 |
| Jun 11, 2025 | PPLI IAC Inc. | MOption exercise Restricted Stock Unitsderivative | -2,076 | $0.00 | $0 | 4,152 | Jun 13, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | MOption exercise Common Stock | +871 | $0.00 | $0 | 15,493 | Jun 3, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | MOption exercise Common Stock | +738 | $0.00 | $0 | 16,231 | Jun 3, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | MOption exercise Common Stock | +644 | $0.00 | $0 | 16,875 | Jun 3, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | MOption exercise Restricted Stock Unitsderivative | -644 | $0.00 | $0 | 0 | Jun 3, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | MOption exercise Restricted Stock Unitsderivative | -871 | $0.00 | $0 | 871 | Jun 3, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | MOption exercise Restricted Stock Unitsderivative | -738 | $0.00 | $0 | 1,477 | Jun 3, 2025 |
| Jun 1, 2025 | EXPE Expedia Group, Inc. | AGrant or award Restricted Stock Unitsderivative | +1,499 | $0.00 | $0 | 1,499 | Jun 3, 2025 |
| Apr 1, 2025 | EXPE Expedia Group, Inc. | AGrant or award Stock Unitsderivative | +75 | $0.00 | $0 | 2,670 | Apr 2, 2025 |
| Mar 31, 2025 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +136 | $45.94 | $6,248 | 75,523 | Apr 2, 2025 |
| Jan 6, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | AGrant or award Class A Common Stock | +60,975 | $0.00 | $0 | 602,814 | Jan 8, 2025 |
| Dec 31, 2024 | PPLI IAC Inc. | AGrant or award Common Stock, par value $0.0001 | +145 | $43.14 | $6,255 | 75,387 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.